Pharmaceuticals: Major
US companies operating in the same pharmaceuticals: major industry
The table below has US companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Pfizer, Inc.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.09 T USD | 1,152.93 USD | +0.04% | 4.55 M | 2.22 | 39.18 | 29.43 USD | +95.14% | 0.58% | Health technology | Buy |
 JNJJohnson & Johnson | 650.65 B USD | 269.99 USD | −0.09% | 16.43 M | 2.95 | 31.29 | 8.63 USD | −7.72% | 1.96% | Health technology | Buy |
 ABBVAbbVie Inc. | 466.45 B USD | 263.96 USD | −0.02% | 8.18 M | 1.95 | 74.63 | 3.54 USD | +68.31% | 2.59% | Health technology | Buy |
 MRKMerck & Company, Inc. | 362.35 B USD | 146.87 USD | −0.19% | 31.16 M | 3.85 | 117.39 | 1.25 USD | −80.71% | 2.29% | Health technology | Buy |
 AZNAstraZeneca PLC | 257.57 B USD | 166.08 USD | −0.04% | 3.06 M | 0.92 | 25.14 | 6.61 USD | +17.00% | 0.00% | Health technology | Strong buy |
 NVSNovartis AGDR | 255.41 B USD | 140.37 USD | −0.39% | 2.25 M | 0.74 | 21.18 | 6.63 USD | −4.00% | 2.20% | Health technology | Neutral |
 NVONovo Nordisk A/SDR | 191.08 B USD | 43.24 USD | +0.12% | 10.37 M | 1.13 | 10.57 | 4.09 USD | +12.75% | 2.85% | Health technology | Neutral |
 PFEPfizer, Inc. | 157.65 B USD | 27.66 USD | +0.07% | 75.59 M | 2.61 | 36.63 | 0.76 USD | −59.83% | 6.22% | Health technology | Neutral |
 VRTXVertex Pharmaceuticals Incorporated | 128.84 B USD | 508.34 USD | −1.55% | 2.43 M | 2.84 | 29.57 | 17.19 USD | +22.86% | 0.00% | Health technology | Buy |
 BMYBristol-Myers Squibb Company | 128.81 B USD | 63.06 USD | +0.35% | 36.85 M | 4.65 | 13.89 | 4.54 USD | +83.17% | 3.98% | Health technology | Buy |
 SNYSanofiDR | 101.94 B USD | 42.48 USD | −1.53% | 2.24 M | 0.96 | 21.88 | 1.94 USD | −30.91% | 4.15% | Health technology | Buy |
 GSKGSK plcDR | 100.46 B USD | 50.22 USD | −1.65% | 4.71 M | 1.79 | 15.82 | 3.17 USD | +47.95% | 3.56% | Health technology | Neutral |
 REGNRegeneron Pharmaceuticals, Inc. | 80.8 B USD | 784.85 USD | −0.58% | 2.47 M | 4.56 | 19.40 | 40.46 USD | +1.95% | 0.47% | Health technology | Buy |
 TAKTakeda Pharmaceutical Company LimitedDR | 61.05 B USD | 18.91 USD | −0.73% | 2.96 M | 1.25 | — | −0.34 USD | −214.18% | 3.09% | Health technology | Buy |
 HLNHaleon plcDR | 40.01 B USD | 9.28 USD | −0.85% | 45.17 M | 2.57 | 19.08 | 0.49 USD | +12.39% | 2.02% | Health technology | Buy |
 ONCBeOne Medicines Ltd.DR | 40.01 B USD | 350.84 USD | −0.74% | 438.38 K | 1.14 | 61.65 | 5.69 USD | — | 0.00% | Health technology | Strong buy |
 RPRXRoyalty Pharma plc | 33.59 B USD | 58.41 USD | −0.88% | 7.1 M | 2.03 | 31.09 | 1.88 USD | −18.22% | 1.58% | Health technology | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 32.06 B USD | 239.56 USD | −2.42% | 2.76 M | 1.91 | 40.45 | 5.92 USD | — | 0.00% | Health technology | Buy |
 BIIBBiogen Inc. | 31.84 B USD | 215.50 USD | −1.62% | 2.64 M | 3.68 | 38.16 | 5.65 USD | −45.98% | 0.00% | Health technology | Buy |
 ZTSZoetis Inc. | 29.5 B USD | 71.40 USD | −2.22% | 9.88 M | 2.17 | 11.75 | 6.08 USD | +4.59% | 2.93% | Health technology | Buy |
 ROIVRoivant Sciences Ltd. | 28.73 B USD | 39.77 USD | −0.53% | 32.2 M | 3.58 | — | −0.44 USD | +37.24% | 0.00% | Health technology | Strong buy |
 INSMInsmed Incorporated | 26.21 B USD | 120.00 USD | −3.21% | 3.45 M | 1.69 | — | −4.11 USD | +28.02% | 0.00% | Health technology | Strong buy |
 INCYIncyte Corporation | 25.4 B USD | 125.31 USD | −1.81% | 3.7 M | 2.79 | 15.97 | 7.85 USD | +78.38% | 0.00% | Health technology | Buy |
 VTRSViatris Inc. | 19.47 B USD | 16.95 USD | −1.05% | 15.65 M | 2.08 | — | −0.36 USD | +87.72% | 2.83% | Health technology | Buy |
 JAZZJazz Pharmaceuticals plc | 15.63 B USD | 240.74 USD | −1.27% | 2.21 M | 4.02 | 16.60 | 14.50 USD | — | 0.00% | Health technology | Strong buy |
 ASNDAscendis Pharma A/S | 14.77 B USD | 236.72 USD | −0.97% | 1.56 M | 1.63 | 18.04 | 13.12 USD | — | 0.00% | Health technology | Strong buy |
 EXELExelixis, Inc. | 14.46 B USD | 58.36 USD | −0.22% | 5.24 M | 2.61 | 18.33 | 3.18 USD | +52.70% | 0.00% | Health technology | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 12.28 B USD | 531.52 USD | −0.54% | 330.62 K | 1.59 | — | −12.88 USD | −0.28% | 0.00% | Health technology | Strong buy |
 CORTCorcept Therapeutics Incorporated | 11.92 B USD | 110.29 USD | −3.98% | 17.23 M | 19.06 | 263.41 | 0.42 USD | −62.74% | 0.00% | Health technology | Buy |
 RDYDr. Reddy's Laboratories LtdDR | 10.19 B USD | 12.19 USD | 0.00% | 1.89 M | 0.58 | 27.39 | 0.45 USD | −44.33% | 0.53% | Health technology | Neutral |
 RGENRepligen Corporation | 9.98 B USD | 176.89 USD | −0.73% | 1.36 M | 1.48 | 241.09 | 0.73 USD | — | 0.00% | Health technology | Strong buy |
 CYTKCytokinetics, Incorporated | 9.56 B USD | 68.78 USD | −1.63% | 4.87 M | 2.87 | — | −7.22 USD | −41.03% | 0.00% | Health technology | Strong buy |
 PTGXProtagonist Therapeutics, Inc. | 9.25 B USD | 143.00 USD | −0.49% | 1.84 M | 3.39 | 137.88 | 1.04 USD | +45.54% | 0.00% | Health technology | Strong buy |
 IBRXImmunityBio, Inc. | 8.99 B USD | 8.48 USD | +0.24% | 18.43 M | 1.95 | — | −0.97 USD | −96.55% | 0.00% | Health technology | Strong buy |
 TGTXTG Therapeutics, Inc. | 8.71 B USD | 56.87 USD | +0.71% | 5.17 M | 3.51 | 20.71 | 2.75 USD | +633.70% | 0.00% | Health technology | Strong buy |
 PRAXPraxis Precision Medicines, Inc. | 8.35 B USD | 298.95 USD | −3.71% | 829.85 K | 2.69 | — | −12.94 USD | −5.32% | 0.00% | Health technology | Strong buy |
 SYRESpyre Therapeutics, Inc. | 7.96 B USD | 90.25 USD | −2.62% | 3.36 M | 3.18 | — | −2.18 USD | +28.51% | 0.00% | Health technology | Strong buy |
 IONSIonis Pharmaceuticals, Inc. | 7.39 B USD | 44.44 USD | −4.94% | 7.37 M | 1.50 | — | −3.47 USD | −87.55% | 0.00% | Health technology | Buy |
 ALKSAlkermes plc | 7.28 B USD | 43.39 USD | −7.11% | 6.94 M | 4.69 | 112.70 | 0.39 USD | −81.52% | 0.00% | Health technology | Buy |
 BLTEBelite Bio, IncDR | 6.88 B USD | 170.96 USD | +0.36% | 93.89 K | 0.35 | — | −2.73 USD | −76.46% | 0.00% | Health technology | Strong buy |
 RYTMRhythm Pharmaceuticals, Inc. | 6.73 B USD | 97.71 USD | −1.32% | 1.12 M | 1.88 | — | −3.12 USD | −3.31% | 0.00% | Health technology | Strong buy |
 GRFSGrifols, S.A.DR | 6.51 B USD | 7.31 USD | −1.22% | 367.75 K | 0.90 | 9.43 | 0.77 USD | +61.67% | 1.17% | Health technology | Neutral |
 ORKAOruka Therapeutics, Inc. | 6.29 B USD | 94.96 USD | −2.83% | 1.94 M | 2.63 | — | −2.46 USD | +32.27% | 0.00% | Health technology | Strong buy |
 KNSAKiniksa Pharmaceuticals International, plc | 6.03 B USD | 77.24 USD | −2.63% | 1.06 M | 1.83 | 78.54 | 0.98 USD | +2,292.94% | 0.00% | Health technology | Strong buy |
 LQDALiquidia Corporation | 5.99 B USD | 66.88 USD | −2.21% | 3.9 M | 3.63 | 49.02 | 1.36 USD | — | 0.00% | Health technology | Buy |
 AMRXAmneal Pharmaceuticals, Inc. | 5.98 B USD | 18.71 USD | +2.35% | 6.62 M | 3.12 | 39.04 | 0.48 USD | +7,387.50% | 0.00% | Health technology | Strong buy |
 MIRMMirum Pharmaceuticals, Inc. | 5.96 B USD | 91.83 USD | −7.07% | 1.8 M | 2.83 | — | −14.55 USD | −1,101.55% | 0.00% | Health technology | Strong buy |
 TVTXTravere Therapeutics, Inc. | 5.92 B USD | 62.76 USD | −3.06% | 2.24 M | 1.59 | — | −0.76 USD | +62.56% | 0.00% | Health technology | Strong buy |
 LGNDLigand Pharmaceuticals Incorporated | 5.65 B USD | 283.49 USD | −0.43% | 372.8 K | 1.74 | 30.31 | 9.35 USD | — | 0.00% | Health technology | Strong buy |
 PTCTPTC Therapeutics, Inc. | 5.46 B USD | 65.37 USD | −3.87% | 3.86 M | 3.91 | — | −0.59 USD | −108.51% | 0.00% | Health technology | Buy |
 DFTXDefinium Therapeutics, Inc. | 5.21 B USD | 38.81 USD | +0.34% | 3.22 M | 1.33 | — | −3.44 USD | −134.91% | 0.00% | Health technology | Strong buy |
 ERASErasca, Inc. | 5.17 B USD | 14.77 USD | −3.72% | 8.69 M | 1.89 | — | −0.95 USD | −110.63% | 0.00% | Health technology | Strong buy |
| PPBLSParabilis Medicines, Inc. | 5.16 B USD | 41.73 USD | +2.08% | 9.09 M | 15.42 | — | — | — | 0.00% | Health technology | Strong buy |
 ACADACADIA Pharmaceuticals Inc. | 4.7 B USD | 27.29 USD | −0.58% | 5.48 M | 3.94 | 12.29 | 2.22 USD | +66.85% | 0.00% | Health technology | Buy |
 MANEVeradermics, Incorporated | 4.46 B USD | 106.75 USD | −1.78% | 1.87 M | 3.04 | — | — | — | 0.00% | Health technology | Strong buy |
 INDVIndivior Pharmaceuticals, Inc. | 4.12 B USD | 34.88 USD | −2.27% | 4.68 M | 2.42 | 12.39 | 2.82 USD | +297.21% | 0.00% | Health technology | Strong buy |
 AMLXAmylyx Pharmaceuticals, Inc. | 4.07 B USD | 32.41 USD | −4.51% | 2.05 M | 1.36 | — | −1.43 USD | +42.67% | 0.00% | Health technology | Strong buy |
 XENEXenon Pharmaceuticals Inc. | 3.85 B USD | 39.75 USD | −30.69% | 17.95 M | 26.22 | — | −4.74 USD | −33.88% | 0.00% | Health technology | Strong buy |
 IDYAIDEAYA Biosciences, Inc. | 3.71 B USD | 38.41 USD | −0.52% | 2.49 M | 4.25 | — | −1.94 USD | +48.68% | 0.00% | Health technology | Strong buy |
 TARSTarsus Pharmaceuticals, Inc. | 3.65 B USD | 78.09 USD | −1.19% | 710.97 K | 0.88 | — | −1.08 USD | +53.58% | 0.00% | Health technology | Strong buy |
 OGNOrganon & Co. | 3.59 B USD | 13.68 USD | −0.07% | 4.94 M | 1.77 | 17.52 | 0.78 USD | −71.01% | 0.58% | Health technology | Neutral |
 LEGNLegend Biotech CorporationDR | 3.41 B USD | 17.61 USD | +0.17% | 2.94 M | 1.26 | — | −0.51 USD | +71.61% | 0.00% | Health technology | Buy |
 VKTXViking Therapeutics, Inc. | 3.38 B USD | 28.99 USD | −1.26% | 2.67 M | 1.31 | — | −4.66 USD | −203.77% | 0.00% | Health technology | Strong buy |
 ARQTArcutis Biotherapeutics, Inc. | 3.19 B USD | 25.38 USD | −4.08% | 19.14 M | 6.39 | 122.55 | 0.21 USD | — | 0.00% | Health technology | Strong buy |
 RGCRegencell Bioscience Holdings Limited | 2.87 B USD | 5.79 USD | −2.85% | 94.3 K | 0.40 | — | −0.01 USD | −71.08% | 0.00% | Health technology | No rating |
 NAMSNewAmsterdam Pharma Company N.V. | 2.69 B USD | 22.49 USD | +2.55% | 2.08 M | 1.15 | — | −2.18 USD | −35.06% | 0.00% | Health technology | Strong buy |
| BBRVEBraveheart Bio, Inc. | 2.63 B USD | 29.20 USD | +5.38% | 2.02 M | 5.45 | — | — | — | 0.00% | Health technology | Strong buy |
 GPCRStructure Therapeutics Inc.DR | 2.5 B USD | 35.00 USD | −0.28% | 1.55 M | 1.13 | — | −3.08 USD | +1.47% | 0.00% | Health technology | Strong buy |
 VRDNViridian Therapeutics, Inc. | 2.49 B USD | 22.00 USD | +0.32% | 5.38 M | 4.12 | — | −3.71 USD | +13.06% | 0.00% | Health technology | Strong buy |
 HRMYHarmony Biosciences Holdings, Inc. | 2.45 B USD | 42.02 USD | −1.68% | 3.82 M | 3.46 | 13.62 | 3.09 USD | −0.53% | 0.00% | Health technology | Buy |
 SUPNSupernus Pharmaceuticals, Inc. | 2.45 B USD | 42.00 USD | −2.14% | 1.18 M | 1.98 | — | −1.91 USD | −267.30% | 0.00% | Health technology | Buy |
 HCMHUTCHMED (China) LimitedDR | 2.39 B USD | 13.67 USD | −1.09% | 15.79 K | 0.13 | 134.41 | 0.10 USD | −96.21% | 0.00% | Health technology | Strong buy |
 SLSSELLAS Life Sciences Group, Inc. | 2.32 B USD | 11.49 USD | −0.35% | 14.61 M | 2.18 | — | −0.21 USD | +35.38% | 0.00% | Health technology | Strong buy |
 NKTRNektar Therapeutics | 2.29 B USD | 67.10 USD | −1.84% | 2.81 M | 3.03 | — | −6.70 USD | +23.18% | 0.00% | Health technology | Strong buy |
 OCULOcular Therapeutix, Inc. | 2.19 B USD | 9.99 USD | −1.48% | 4.1 M | 1.75 | — | −1.41 USD | −10.60% | 0.00% | Health technology | Strong buy |
 PBHPrestige Consumer Healthcare Inc. | 2.13 B USD | 44.97 USD | −3.23% | 2.02 M | 3.97 | 12.59 | 3.57 USD | −16.20% | 0.00% | Health technology | Buy |
 SRPTSarepta Therapeutics, Inc. | 2.12 B USD | 20.11 USD | −2.71% | 6.29 M | 2.10 | — | −2.90 USD | −281.95% | 0.00% | Health technology | Neutral |
 BHVNBiohaven Ltd. | 2.06 B USD | 13.62 USD | −1.94% | 6.43 M | 1.88 | — | −4.65 USD | +39.33% | 0.00% | Health technology | Buy |
 VCELVericel Corporation | 2.05 B USD | 40.02 USD | −0.02% | 1.13 M | 2.48 | 86.59 | 0.46 USD | +270.65% | 0.00% | Health technology | Strong buy |
 AGIOAgios Pharmaceuticals, Inc. | 1.97 B USD | 33.07 USD | −1.61% | 1.57 M | 1.89 | — | −7.01 USD | −163.46% | 0.00% | Health technology | Buy |
 GHRSGH Research PLC | 1.94 B USD | 28.26 USD | −1.60% | 132.83 K | 0.67 | — | −0.99 USD | −33.76% | 0.00% | Health technology | Strong buy |
 ZYMEZymeworks Inc. | 1.9 B USD | 26.57 USD | −3.31% | 1.1 M | 1.57 | — | −2.01 USD | −105.50% | 0.00% | Health technology | Strong buy |
 PRGOPerrigo Company plc | 1.88 B USD | 13.56 USD | +0.59% | 6.88 M | 3.10 | — | −12.51 USD | −2,139.20% | 8.55% | Health technology | Buy |
 NBTXNanobiotix S.A.DR | 1.73 B USD | 33.05 USD | −7.89% | 149.34 K | 1.16 | — | −0.57 USD | +50.79% | 0.00% | Health technology | Strong buy |
 ETONEton Pharmaceuticals, Inc. | 1.59 B USD | 55.50 USD | −2.75% | 891.7 K | 2.26 | 146.75 | 0.38 USD | — | 0.00% | Health technology | Strong buy |
 INVAInnoviva, Inc. | 1.53 B USD | 21.14 USD | +0.43% | 1.44 M | 1.73 | 5.15 | 4.10 USD | +1,137.16% | 0.00% | Health technology | Buy |
 BCAXBicara Therapeutics Inc. | 1.5 B USD | 22.64 USD | +0.22% | 934.23 K | 1.74 | — | −3.09 USD | −63.70% | 0.00% | Health technology | Strong buy |
| LLTGOLatigo Biotherapeutics, Inc. | 1.5 B USD | 22.55 USD | −5.77% | 1.49 M | 5.75 | — | — | — | 0.00% | Health technology | Strong buy |
 RAREUltragenyx Pharmaceutical Inc. | 1.43 B USD | 14.51 USD | +0.07% | 13.34 M | 1.57 | — | −5.84 USD | −5.66% | 0.00% | Health technology | Buy |
 PAHCPhibro Animal Health Corporation | 1.4 B USD | 34.56 USD | +0.33% | 635.51 K | 2.94 | 14.20 | 2.43 USD | +105.22% | 1.39% | Health technology | Neutral |
 AVLNAvalyn Pharma Inc. | 1.4 B USD | 31.52 USD | −5.71% | 664.78 K | 2.76 | — | — | — | 0.00% | Health technology | Strong buy |
 AAPGAscentage Pharma Group International - American Depository SharesDR | 1.4 B USD | 15.06 USD | −2.02% | 2.07 K | 0.33 | — | −2.26 USD | −12.46% | 0.00% | Health technology | Strong buy |
| DDMRADamora Therapeutics, Inc. | 1.39 B USD | 22.59 USD | −0.83% | 3.32 M | 4.92 | — | −124.78 USD | −850.33% | 0.00% | Health technology | Strong buy |
 LBRXLB Pharmaceuticals Inc | 1.37 B USD | 42.47 USD | +0.78% | 531.64 K | 2.15 | — | −2.98 USD | −132.05% | 0.00% | Health technology | Strong buy |
 CGEMCullinan Therapeutics, Inc. | 1.36 B USD | 21.08 USD | −1.31% | 3.25 M | 3.50 | — | −3.39 USD | +3.56% | 0.00% | Health technology | Strong buy |
 ORICOric Pharmaceuticals, Inc. | 1.33 B USD | 12.79 USD | −0.70% | 3.09 M | 2.37 | — | −1.35 USD | +28.64% | 0.00% | Health technology | Strong buy |
 OMEROmeros Corporation | 1.29 B USD | 17.87 USD | −3.14% | 2.15 M | 1.45 | 12.43 | 1.44 USD | — | 0.00% | Health technology | Buy |
 IMTXImmatics N.V. | 1.29 B USD | 8.62 USD | −2.27% | 759.92 K | 1.46 | — | −1.85 USD | −164.71% | 0.00% | Health technology | Strong buy |
 MAZEMaze Therapeutics, Inc. | 1.25 B USD | 22.52 USD | −3.92% | 1.49 M | 2.70 | — | −2.53 USD | −50.45% | 0.00% | Health technology | Strong buy |
 HROWHarrow, Inc. | 1.24 B USD | 33.08 USD | −0.15% | 1.74 M | 3.27 | — | −1.00 USD | −236.87% | 0.00% | Health technology | Strong buy |